18 results
SC TO-T
EX-99
TAK
Takeda Pharmaceutical Co
30 Apr 18
Third party tender offer statement
6:13am
Lead, Data Privacy
Date: 14/02/2018
For and on behalf of TiGenix NV
Name: Eduardo Bravo
Title: CEO
Date:
For and on behalf of Takeda Pharmaceutical
6-K
TAK
Takeda Pharmaceutical Co
29 May 20
Current report (foreign)
6:20am
clinical trial data and biosamples that benefit patients and foster scientific discovery in a way that ensures patient consent to the use of the data … , privacy and preserves the integrity of research.
Assets and liabilities related to SHP647, which were previously classified as held for sale
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
17 Dec 20
Current report (foreign)
6:01am
Drug Program Tax Transparency Lifelong Learning Speed of Product Development Data Privacy & Security Waste & Water Management Patient Health Care … covers areas that include the environment, human rights, labor practices, safe work, data privacy, anti-corruption, business practices, animal welfare
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
30 May 23
Current report (foreign)
6:19am
to manage our exposure to digital threats and strengthen adherence to compliance and data privacy standards across our online channels. Our significant
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
10 Jan 20
Better Health, Brighter Future 2019 SUSTAINABLE VALUE REPORT Takeda Pharmaceutical Company Limited
6:36am
Measuring Supplier Animal welfare Strategic Sustainability Data privacy Social, ethical & environmental Performance & Risk Human rights Labor & employment … — with a focus on rights, financial health, corruption and bribery, and social, environmental, and economic good. data privacy and information
DRS/A
htra xtiz7wnnj4vevqc
16 Nov 18
Draft registration statement (amended)
12:00am
20FR12B/A
audx4otq
17 Dec 18
Initial registration of securities (foreign private issuers) (amended)
6:14am
20-F
l8wu k1ek
27 Jun 19
Annual report (foreign)
6:41am
20FR12B
yxwmvjexw02q5u
6 Dec 18
Initial registration of securities (foreign private issuers)
10:39am
F-4/A
9cv a4dbxr2
12 Nov 19
Registration of securities (foreign) (amended)
9:50am
6-K
EX-99.1
du37wvmd5vmxifnq
29 Jun 21
Current report (foreign)
7:38am
F-4
3utb9b6qc3aut rlbn
9 Aug 19
Registration of securities (foreign)
6:27am
424B3
x8vruz8l ph3ca
14 Nov 19
Prospectus supplement
6:10am
- Prev
- 1
- Next